Market Tracker

08/26 5:16pm ET

Biospecifics Technologies Corp (NASDAQ:BSTC)

36.98
Delayed Data
As of Aug 26
 +0.54 / +1.48%
Today’s Change
30.70
Today|||52-Week Range
63.20
-13.94%
Year-to-Date
Forget Mylan, Buy These 3 Drug Stocks Instead
Aug 26 / Zacks.com - Paid Partner Content
Catalyst Pharmaceuticals (CPRX) Looks Good: Stock Up 6.3%
Aug 18 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for August 22nd
Aug 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close36.44
Today’s open36.66
Day’s range36.41 - 37.16
Volume27,454
Average volume (3 months)43,926
Market cap$259.3M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+100.00%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+61.61%
P/E ratio24.8
Price/Sales13.74
Price/Book5.71

Competitors

 Today’s
change
Today’s
% change
ENZEnzo Biochem Inc+0.01+0.18%
NVIVInVivo Therapeutics ...+0.02+0.28%
SNMXSenomyx Inc+0.41+10.02%
RGNXRegenxbio Inc-0.08-0.64%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)$0.41
Annual revenue (last year)$22.8M
Annual profit (last year)$9.6M
Net profit margin42.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Thomas L. Wegman
Controller
James Goris
Corporate headquarters
Lynbrook, New York

Forecasts